|By Business Wire||
|March 21, 2014 07:00 AM EDT||
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, was featured in an article published by Fast Company Co.Exist on March 19.
The article, “Lab-Grown Organs Are Out In The Wild, And More Are Coming Soon,” recounts the Company’s success to date in regenerating tracheas and the technology involved. It additionally notes the Company “sees a booming business in lab-grown organs” and that it is “the only organization to approach the FDA and the EMA about clinical trials to take the technology to market.”
To read the Fast Company Co.Exist article in its entirety, please visit the following link: http://www.fastcoexist.com/3027468/lab-grown-organs-are-out-in-the-wild-and-more-are-coming-soon
The article at the link above is provided for informational purposes only. Harvard Apparatus Regenerative Technology, Inc. is not responsible for the content of the linked article.
About Harvard Apparatus Regenerative Technology
Harvard Apparatus Regenerative Technology makes regenerated organs for transplant. Our first product, the InBreathTM Airway Transplant System, is intended to replace or repair a trachea that has been severely damaged by either trachea cancer or physical trauma. Our technology has been used in eight human trachea transplants to date approved under compassionate use exemptions, but none of our products are yet approved by a government regulatory authority for marketing. On November 1, 2013, HART was spun-off from Harvard Bioscience. The trademark “Harvard Apparatus” is used under a sublicense agreement with Harvard Bioscience, who has licensed the right to use such trademark from Harvard University.
Some of the statements in this press release are "forward-looking" and are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These "forward-looking" statements include statements relating to, among other things, the planned commercialization efforts and marketing approvals of HART’s products as well as the success thereof and the availability of a market for the HART securities. These statements involve risks and uncertainties, including among other things, market conditions that may cause results to differ materially from the statements set forth in this press release. The forward-looking statements in this press release speak only as of the date of this press release. Harvard Apparatus Regenerative Technology expressly disclaims any obligation or undertaking to release publicly any updates or revisions to such statements to reflect any change in its expectations with regard thereto or any changes in the events, conditions or circumstances on which any such statement is based.
Oct. 6, 2015 09:00 PM EDT Reads: 227
Oct. 6, 2015 08:15 PM EDT Reads: 341
Oct. 6, 2015 08:00 PM EDT Reads: 307
Oct. 6, 2015 05:00 PM EDT Reads: 250
Oct. 6, 2015 04:40 PM EDT
Oct. 6, 2015 03:00 PM EDT Reads: 116
Oct. 6, 2015 02:45 PM EDT Reads: 370
Oct. 6, 2015 02:00 PM EDT Reads: 227
Oct. 6, 2015 01:00 PM EDT Reads: 580
Oct. 6, 2015 01:00 PM EDT Reads: 738
Oct. 6, 2015 12:45 PM EDT Reads: 458
Oct. 6, 2015 12:30 PM EDT Reads: 581
Oct. 6, 2015 12:15 PM EDT Reads: 107
DevOps is gaining traction in the federal government – and for good reasons. Heightened user expectations are pushing IT organizations to accelerate application development and support more innovation. At the same time, budgetary constraints require that agencies find ways to decrease the cost of developing, maintaining, and running applications. IT now faces a daunting task: do more and react faster than ever before – all with fewer resources.
Oct. 6, 2015 12:00 PM EDT Reads: 338
SYS-CON Events announced today that VividCortex, the monitoring solution for the modern data system, will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. The database is the heart of most applications, but it’s also the part that’s hardest to scale, monitor, and optimize even as it’s growing 50% year over year. VividCortex is the first unified suite of database monitoring tools specifically desi...
Oct. 6, 2015 12:00 PM EDT Reads: 411